Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ramlau

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 31, 2012
Structural transformation with "negative volume expansion": chemical bonding and physical behavior of TiGePtS-V Ackerbauer, A Senyshyn, H Borrmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2007
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancerR Rosell, G Robinet, A Szczesna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2010
A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancerE-H Tan, R Ramlau, A Pluzanska, et al.
Lung Cancer (Amsterdam, Netherlands)|August 21, 2009
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancerGiorgio V Scagliotti, Paul Germonpré, Leon Bosquée, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2015
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancerG Giaccone, L A Bazhenova, J Nemunaitis, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 31, 2012
Structural transformation with "negative volume expansion": chemical bonding and physical behavior of TiGePtS-V Ackerbauer, A Senyshyn, H Borrmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2007
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancerR Rosell, G Robinet, A Szczesna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2010
A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancerE-H Tan, R Ramlau, A Pluzanska, et al.
Lung Cancer (Amsterdam, Netherlands)|August 21, 2009
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancerGiorgio V Scagliotti, Paul Germonpré, Leon Bosquée, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2015
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancerG Giaccone, L A Bazhenova, J Nemunaitis, et al.
Pageof 3